title: Halothane inhibits binding of calcium channel blockers to cardiac sarcolemma.
authors.affiliation: Department of Anesthesiology, Hadassah Hospital, Jerusalem, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Drenger
authors.forename: S R
authors.initials: SR
authors.lastname: Runge
authors.forename: P
authors.initials: P
authors.lastname: Hoehner
authors.forename: M
authors.initials: M
authors.lastname: Quigg
authors.forename: T J
authors.initials: TJ
authors.lastname: Blanck
mesh_terms: D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics*; D002417:Cattle; D003864:Depression, Chemical; D004285:Dogs; D005711:Gallopamil / Q000494:pharmacology; D006221:Halothane / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism*; D009568:Nitrendipine / Q000493:pharmacokinetics; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism*
chemical_list: D002121:Calcium Channel Blockers; D005711:Gallopamil; D009568:Nitrendipine; D006221:Halothane